Skip to content

A study to evaluate the effect of hyperbaric oxygen therapy along with local antibiotic therapy and wound care in the healing of infected pressure ulcers.

A prospective randomised control trial to evaluate the effect of adjunctive hyperbaric oxygen therapy in the clinical and microbiological outcome of infected pressure ulcers.

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/10/028668
Enrollment
30
Registered
2020-10-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue

Interventions

Intervention1: Hyperbaric Oxygen therapy(Group H): The wounds of all selected patients based on well defined inclusion criterias will be clinically evaluated and documented which includes site, du

Sponsors

Dr Haritha I
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients above the age >18 years and 2. Patients with infected pressure ulcers as evidenced by positive gram stain/ wound cultures 3. Who give consent to take part in the study

Exclusion criteria

Exclusion criteria: Exclusion Criteria : 1. Patients who do not give consent 2. Age 60years 3.Patients with pneumothorax, COPD 4.Patients with ejection fraction less than 35 % 5.Pregnant patients, Post chemotherapy patients. 8 .Patients with ear disease seizure disorders, hereditary Spherocytosis

Design outcomes

Primary

MeasureTime frame
To compare the clinical effect of hyperbaric oxygen therapy on pressure ulcers by serially assessing change in PUSH score ( Pressure Ulcer Scale for Healing) of the wound. To compare the microbiological effect of hyperbaric oxygen therapy on pressure ulcers by serially evaluating the change in colony forming units of microorganisms isolated from the wound culture as per standard microbiological techniques Timepoint: 15 days

Secondary

MeasureTime frame
To compare the mean duration of hospital stay in both groups.To assess the total number of patients requiring debridement in both groups Timepoint: 12 months

Countries

India

Contacts

Public ContactDr Haritha I

AIIMS , Rishikesh

ankit.anaes@aiimsishikesh.edu.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026